MacroGenics Statistics

Total Valuation

MacroGenics has a market cap or net worth of $305.74 million. The enterprise value is $188.02 million.

Market Cap	305.74M
Enterprise Value	188.02M

Important Dates

The next estimated earnings date is Thursday, August 13, 2026, after market close.

Earnings Date	Aug 13, 2026
Ex-Dividend Date	n/a

Share Statistics

MacroGenics has 63.56 million shares outstanding. The number of shares has increased by 0.77% in one year.

Current Share Class	63.56M
Shares Outstanding	63.56M
Shares Change (YoY)	+0.77%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	2.63%
Owned by Institutions (%)	55.21%
Float	52.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.95
Forward PS	2.55
PB Ratio	14.42
P/TBV Ratio	14.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.90, with a Debt / Equity ratio of 1.72.

Current Ratio	1.90
Quick Ratio	1.72
Debt / Equity	1.72
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.78

Financial Efficiency

Return on equity (ROE) is -140.27% and return on invested capital (ROIC) is -45.65%.

Return on Equity (ROE)	-140.27%
Return on Assets (ROA)	-17.98%
Return on Invested Capital (ROIC)	-45.65%
Return on Capital Employed (ROCE)	-52.21%
Weighted Average Cost of Capital (WACC)	12.77%
Revenue Per Employee	$536,119
Profits Per Employee	-$240,130
Employee Count	293
Asset Turnover	0.71
Inventory Turnover	19.30

Taxes

Income Tax	-672,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +267.18% in the last 52 weeks. The beta is 1.20, so MacroGenics's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	+267.18%
50-Day Moving Average	3.83
200-Day Moving Average	2.40
Relative Strength Index (RSI)	66.91
Average Volume (20 Days)	1,195,371

Short Selling Information

The latest short interest is 4.98 million, so 7.83% of the outstanding shares have been sold short.

Short Interest	4.98M
Short Previous Month	4.88M
Short % of Shares Out	7.83%
Short % of Float	9.49%
Short Ratio (days to cover)	5.94

Income Statement

In the last 12 months, MacroGenics had revenue of $157.08 million and -$70.36 million in losses. Loss per share was -$1.11.

Revenue	157.08M
Gross Profit	-25.50M
Operating Income	-63.66M
Pretax Income	-71.03M
Net Income	-70.36M
EBITDA	-56.57M
EBIT	-63.66M
Loss Per Share	-$1.11

Full Income Statement

Balance Sheet

The company has $154.23 million in cash and $36.51 million in debt, giving a net cash position of $117.72 million or $1.85 per share.

Cash & Cash Equivalents	154.23M
Total Debt	36.51M
Net Cash	117.72M
Net Cash Per Share	$1.85
Equity (Book Value)	21.20M
Book Value Per Share	0.33
Working Capital	86.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$69.96 million and capital expenditures -$1.73 million, giving a free cash flow of -$71.69 million.

Operating Cash Flow	-69.96M
Capital Expenditures	-1.73M
Depreciation & Amortization	7.09M
Net Borrowing	n/a
Free Cash Flow	-71.69M
FCF Per Share	-$1.13

Full Cash Flow Statement

Margins

Gross margin is -16.24%, with operating and profit margins of -40.52% and -44.79%.

Gross Margin	-16.24%
Operating Margin	-40.52%
Pretax Margin	-45.22%
Profit Margin	-44.79%
EBITDA Margin	-36.01%
EBIT Margin	-40.52%
FCF Margin	n/a

Dividends & Yields

MacroGenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.77%
Shareholder Yield	-0.77%
Earnings Yield	-23.01%
FCF Yield	-23.45%

Analyst Forecast

The average price target for MacroGenics is $6.75, which is 40.33% higher than the current price. The consensus rating is "Buy".

Price Target	$6.75
Price Target Difference	40.33%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (3Y)	-3.35%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MacroGenics has an Altman Z-Score of -7.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.67
Piotroski F-Score	3